These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3195414)

  • 1. [Comparison of enoxacin, ofloxacin, and norfloxacin concentration in human benign prostatic tissue].
    Yasumoto R; Asakawa M
    Hinyokika Kiyo; 1988 Aug; 34(8):1519-21. PubMed ID: 3195414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ofloxacin concentration in human benign prostatic tissue after oral administration.
    Asakawa M; Yasumoto R
    Hinyokika Kiyo; 1988 Jun; 34(6):1097-9. PubMed ID: 2464915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The penetration of ofloxacin and enoxacin into the alveolar spaces in rats].
    Kato M; Tashiro T; Yoshitomo K; Hayashi Y; Ito G; Yamamoto K; Yamada Y; Takeuchi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Oct; 28(10):1338-43. PubMed ID: 2273663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diffusion of ofloxacin (OFLX) into prostatic tissue in patients with benign prostatic hypertrophy].
    Uchibayashi T; Nagano K; Shoda R; Hisazumi H; Sawaki M; Yamaguchi K; Kawaguchi K; Komatsu K; Kobashi K; Koizumi H
    Hinyokika Kiyo; 1990 Jun; 36(6):741-5. PubMed ID: 1700587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ofloxacin and norfloxacin concentration in prostatic tissues in patients undergoing transurethral resection of the prostate.
    Chen J; Chen RR; Huang HS
    J Formos Med Assoc; 2001 Aug; 100(8):548-52. PubMed ID: 11678006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enoxacin concentration in human prostatic tissue after 3-day administration].
    Morita M; Kato M; Kuji S; Hasuda A
    Hinyokika Kiyo; 1988 Jul; 34(7):1293-6. PubMed ID: 2459943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Norfloxacin concentration in human prostatic tissue after 3 days administration].
    Morita M; Hasuda A
    Hinyokika Kiyo; 1989 Jul; 35(7):1261-5. PubMed ID: 2478009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enoxacin concentration in human prostatic tissue].
    Yasumoto R; Kobayakawa H; Asakawa M
    Hinyokika Kiyo; 1986 Oct; 32(10):1471-3. PubMed ID: 2436463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concentrations of new quinolone agents in serum and prostate tissue].
    Imai K; Suzuki K; Yamanaka H; Makino T; Yazima H; Takezawa Y; Kitaura K; Shiono A; Sato J; Kato N
    Hinyokika Kiyo; 1994 May; 40(5):401-6. PubMed ID: 7517621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on enoxacin concentration in human prostatic tissue].
    Kitamura Y; Kataumi Z; Nakamura T; Takeda H
    Hinyokika Kiyo; 1990 Jan; 36(1):101-2. PubMed ID: 1689927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ofloxacin concentration in human prostatic tissue after 3 days of administration].
    Morita M; Hasuda A
    Hinyokika Kiyo; 1989 Jan; 35(1):187-90. PubMed ID: 2729016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ofloxacin concentration in prostatic tissue].
    Kawauchi A; Kamoi K; Ohne T; Imada N; Kitamori T; Terasaki T; Watanabe H
    Hinyokika Kiyo; 1993 Dec; 39(12):1191-3. PubMed ID: 7506868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diffusion of enoxacin into the prostatic fluid in the chronic prostatitis patient].
    Tanaka K; Nakano Y; Ono Y; Hirabayashi S; Yamada S
    Hinyokika Kiyo; 1988 Nov; 34(11):2067-9. PubMed ID: 3242374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enoxacin in the seminal fluid of prostatitis patients].
    Yasumoto R; Asakawa M
    Hinyokika Kiyo; 1988 Jun; 34(6):1101-3. PubMed ID: 3223456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of inhibitory effects of new quinolones on drug metabolizing activity in the liver.
    Nakanishi S; Okuno H
    Jpn J Pharmacol; 1990 May; 53(1):81-96. PubMed ID: 2352379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic significance of measurement of salivary penetration of protein-unbound pyridonecarboxylic acid antimicrobial agents].
    Uematsu M
    Shikwa Gakuho; 1989 Jan; 89(1):127-53. PubMed ID: 2762850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and prostatic tissue concentrations of ofloxacin.
    Fujita K; Munakata A
    Clin Ther; 1988; 10 Spec No():32-5. PubMed ID: 3233627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dynamics of fluoroquinolone agents in tear fluid--a comparison of the dynamic in tears of human and rabbit eyes].
    Fukuda M; Murano H; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1994 Aug; 98(8):721-6. PubMed ID: 7942332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.